erwinase 10 000 u powder for solution for injection/infusion
porton biopharma limited - crisantaspase - powder for solution for injection/infusion - 10,000 unit(s) - asparaginase
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
erwinase crisantaspase 10,000 iu/3ml powder for injection/infusion vial
ppd australia pty ltd - crisantaspase, quantity: 10000 u - injection, powder for - excipient ingredients: sodium chloride; glucose monohydrate; acetic acid; sodium hydroxide - erwinase is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (all) who have developed hypersensitivity to pegylated asparaginase obtained from e. coli.
rylaze solution
jazz pharmaceuticals ireland limited - crisantaspase - solution - 10mg - crisantaspase 10mg
erwinase 10,000unit powder for solution for injection vials
porton biopharma ltd - crisantaspase - powder for solution for injection - 10000unit
erwinase for intramuscular injection 10000 (アーウィナーゼ筋注用10000)
ohara pharmaceutical co.,ltd. - crisantaspase - injection
erwinase 10,000 units. powder for solution for injection
jazz pharmaceuticals france sas - cristanspase - powder for solution for injection - 10000 international unit(s) - other antineoplastic agents; asparaginase
erwinase 10000 u inj./inf. sol. (pwdr.) i.v./i.m. vial
porton biopharma ltd. - crisantaspase 10000 iu - powder for solution for injection/infusion - asparaginase
erwinase 10 000 e./durchstechflasche pulver zur herstellung einer injektions-/infusionslösung
glibenclamide 2.5mg tablets
wockhardt uk ltd - glibenclamide bp - tablets - 2.5 mg - it is a hypoglycaemic agent indicated in the treatment of non-insulin dependent diabetes in patients who respond inadequately to dietary measures alone